UBS analyst Henry Liu raised the price target on Alibaba Health (241:HK) (NYSE: BABA) to HK$4.70 (from HK$3.80) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE